Implementation and evaluation of a warfarin patient self-management (PSM) program among experienced patients in a U.S. academic health system.
Ryan P FlemingSara R VazquezDaniel M WittPublished in: Journal of thrombosis and thrombolysis (2023)
Warfarin patient self-management (PSM) is when a patient independently manages their warfarin therapy using a decision-support tool provided by their anticoagulation provider. Clinical trials of PSM, conducted predominantly in Europe, have consistently demonstrated superior efficacy without compromising safety. However, the evidence-based practice of PSM is rarely utilized in the United States (U.S.). We describe initiatives completed to implement a successful PSM program among experienced warfarin-taking patients in a U.S. academic health system by overcoming perceived barriers. The results showed PSM resulted in similar or improved INR control, and an estimated 68% reduction in pharmacist workload.
Keyphrases
- atrial fibrillation
- end stage renal disease
- venous thromboembolism
- quality improvement
- newly diagnosed
- chronic kidney disease
- clinical trial
- ejection fraction
- case report
- direct oral anticoagulants
- primary care
- healthcare
- peritoneal dialysis
- prognostic factors
- physical activity
- stem cells
- oral anticoagulants
- mesenchymal stem cells
- study protocol
- open label